Arcutis Biotherapeutics (ARQT) Inventory (2022 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Inventory of $37.4 million for Q1 2026, up 125.06% year-over-year from $16.6 million in Q1 2025, and up 65.2% quarter-over-quarter from $22.6 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Inventory (2022 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Inventory history runs 5 years deep, the most recent figure standing at $37.4 million for Q1 2026.
- In Q1 2026, Inventory rose 125.06% year-over-year to $37.4 million; the TTM figure through Mar 2026 stood at $37.4 million (up 125.06% YoY), while the FY2025 annual figure was $22.6 million, up 55.82% from the prior year.
- Inventory for Q1 2026 stood at $37.4 million, up from $22.6 million in the prior quarter.
- The five-year high for Inventory was $37.4 million in Q1 2026, with the low at $4.3 million in Q3 2022.
- The 5-year median for Inventory is $13.9 million (2023), against an average of $15.3 million.
- The sharpest annual moves came in 2023 and 2024: Inventory soared 223.03% in 2023, then rose 0.73% in 2024.
- Arcutis Biotherapeutics' Inventory stood at $7.5 million in 2022, then jumped by 74.79% to $13.1 million in 2023, then advanced by 10.6% to $14.5 million in 2024, then surged by 55.82% to $22.6 million in 2025, then jumped by 65.2% to $37.4 million in 2026.
- Business Quant data shows ARQT's Inventory at $37.4 million in Q1 2026, $22.6 million in Q4 2025, and $22.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 38.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.88 Mn |
| Mar 31, 2026 | 37.39 Mn |
| Dec 31, 2025 | 22.63 Mn |
| Sep 30, 2025 | 22.42 Mn |
| Jun 30, 2025 | 16.32 Mn |
| Mar 31, 2025 | 16.61 Mn |
| Dec 31, 2024 | 14.53 Mn |
| Sep 30, 2024 | 14.02 Mn |
| Jun 30, 2024 | 13.88 Mn |
| Mar 31, 2024 | 13.25 Mn |
| Dec 31, 2023 | 13.13 Mn |
| Sep 30, 2023 | 13.91 Mn |
| Jun 30, 2023 | 10.47 Mn |
| Mar 31, 2023 | 8.55 Mn |
| Dec 31, 2022 | 7.51 Mn |
| Sep 30, 2022 | 4.31 Mn |